Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03193918
Title Study of Crenolanib With Ramucirumab and Paclitaxel for Advanced Esophagogastric Adenocarcinoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arog Pharmaceuticals, Inc.
Indications

gastric adenocarcinoma

esophagus adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

Crenolanib + Paclitaxel + Ramucirumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.